A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

321

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

July 1, 2020

Study Completion Date

February 28, 2022

Conditions
Stage III Esophageal Squamous Cell Carcinoma
Interventions
DRUG

Paclitaxel and Cisplatin

patients get Paclitaxel and Cisplatin according to protocol

DRUG

Paclitaxel and Fluorouracil

patients get Paclitaxel and Fluorouracil according to protocol

DRUG

Paclitaxel and Carboplatin

patients get Paclitaxel and Carboplatin according to protocol

RADIATION

Radiotherapy

1.8Gy/d, d1-5/week, 34Fx

Trial Locations (1)

200032

Fudan University Cancer Hospital, Shanghai

All Listed Sponsors
collaborator

Huadong Hospital

OTHER

collaborator

Wuxi No. 4 People's Hospital

OTHER

collaborator

Jiangsu Cancer Institute & Hospital

OTHER

collaborator

The First Affiliated Hospital of Xiamen University

OTHER

collaborator

Jiangxi Provincial Cancer Hospital

OTHER

collaborator

Shanxi Province Cancer Hospital

OTHER

collaborator

Gansu Cancer Hospital

OTHER

lead

Fudan University

OTHER

NCT02459457 - A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer | Biotech Hunter | Biotech Hunter